- Home
- Diagnostic
journey
-
Clinician - Suspected CD/ iMCD
Managing a patient with 2+ enlarged lymph nodes and no clear diagnosis / a suspicion of CD / iMCD?
-
Pathologist
Received a lymph node biopsy that needs evaluating for CD / iMCD?
-
Clinician - Confirmed CD/ iMCD
Received a pathology report confirming CD / iMCD features and need to conclude the diagnostic process?
-
- About CD / iMCD
- Resource library
- Pathology tool
Guidance on the assessment of iMCD for pathologists
- Introduction
- EXPERT GUIDANCE ON GRADING, EXCLUSIONS, AND SUBTYPES
- STEP 1: GRADING
- HYPERPLASTIC GERMINAL CENTRES
HYPERPLASTIC GERMINAL CENTRES
Grade 0

Expand
Grade 3

Expand
This tool has been funded and produced by Recordati Rare Diseases (RRD). All images have been
provided by an international
panel of expert pathologists.
The concept, functionality and expert guidance found within this tool
has
also
been developed with the support of expert pathologists.
Prescribing Information
Adverse events should be reported. (UK) Reporting forms and information can be found at
https://yellowcard.mhra.gov.uk/. (Ireland)
Healthcare professionals are requested to report suspected
adverse reactions to HPRA via their website https://www.hpra.ie/. Adverse events should also be reported to
Recordati UK Ltd by telephone: +44 (0)1491 414 333 or email: RRDpharmacovigilance@recordati.com.
This website is developed by Recordati Rare Diseases (RRD) and is intended for use by healthcare
professionals only.
For more information, please contact us at: Email: RRDUnitedKingdominfo@recordati.com Mailing address: Recordati UK Ltd, Breakspear Park, Breakspear Way, Hemel Hempstead HP2 4TZ, United Kingdom
Company reg no: 09329429.
For more information, please contact us at: Email: RRDUnitedKingdominfo@recordati.com Mailing address: Recordati UK Ltd, Breakspear Park, Breakspear Way, Hemel Hempstead HP2 4TZ, United Kingdom
Company reg no: 09329429.